Tags

Type your tag names separated by a space and hit enter

Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis.
Neurotherapeutics 2016; 13(1):47-57N

Abstract

Treatment options in relapsing-remitting multiple sclerosis have increased considerably in recent years; currently, a dozen different preparations of disease-modifying therapies are available and some more are expected to be marketed soon. For the treating neurologist this broad therapeutic repertoire not only greatly improves individualized management of the disease, but also makes choices more complex and difficult. A number of factors must be considered, including disease activity and severity, safety profile, and patient preference. We here discuss the currently existing options and suggest treatment algorithms for managing relapsing-remitting multiple sclerosis.

Authors+Show Affiliations

Department of Neurology, Medical Faculty, University Hospital, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.Department of Neurology, Medical Faculty, University Hospital, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.Department of Neurology, Medical Faculty, University Hospital, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. hans-peter.hartung@uni-duesseldorf.de.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

26701666

Citation

Ingwersen, Jens, et al. "Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis." Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics, vol. 13, no. 1, 2016, pp. 47-57.
Ingwersen J, Aktas O, Hartung HP. Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis. Neurotherapeutics. 2016;13(1):47-57.
Ingwersen, J., Aktas, O., & Hartung, H. P. (2016). Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis. Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics, 13(1), pp. 47-57. doi:10.1007/s13311-015-0412-4.
Ingwersen J, Aktas O, Hartung HP. Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis. Neurotherapeutics. 2016;13(1):47-57. PubMed PMID: 26701666.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis. AU - Ingwersen,Jens, AU - Aktas,Orhan, AU - Hartung,Hans-Peter, PY - 2015/12/25/entrez PY - 2015/12/25/pubmed PY - 2016/11/1/medline KW - Disease-modifying therapy KW - Relapsing-remitting multiple sclerosis KW - Treatment algorithm KW - Treatment decisions SP - 47 EP - 57 JF - Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics JO - Neurotherapeutics VL - 13 IS - 1 N2 - Treatment options in relapsing-remitting multiple sclerosis have increased considerably in recent years; currently, a dozen different preparations of disease-modifying therapies are available and some more are expected to be marketed soon. For the treating neurologist this broad therapeutic repertoire not only greatly improves individualized management of the disease, but also makes choices more complex and difficult. A number of factors must be considered, including disease activity and severity, safety profile, and patient preference. We here discuss the currently existing options and suggest treatment algorithms for managing relapsing-remitting multiple sclerosis. SN - 1878-7479 UR - https://www.unboundmedicine.com/medline/citation/26701666/Advances_in_and_Algorithms_for_the_Treatment_of_Relapsing_Remitting_Multiple_Sclerosis_ L2 - https://dx.doi.org/10.1007/s13311-015-0412-4 DB - PRIME DP - Unbound Medicine ER -